Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The only thing remarkable about George is that he is still a free man.
You cherry picked a snippet of my analysis, which rarely helps any conversation about a complex picture, but in good humor we can make light of things. However, what I think I was describing was a central area, a magnetic hub, an inflection point, and price jiggered around this very area today, to highlight my vision. 😛 so now, we are looking at a pennant , looking upward isn't it? Price is "supposed to" launch upward from this triangle terminal. But the target zone has resistance from 6.00 and up. The Fib tool aligns with the recent pivots, to indicate a "top target zone" 6.80 to 7.10 area. 7.00, and 6.50/6.60 area are all targets I'm watching. A bounce here could be just a 50 cent move to hit 6.00/6.20, also a fib target, and get sold right there. A more bullish rally would be looking to continue a few days or few weeks to the 6.50- 7.00 target area. If we still have weeks and months to wait for major bullish news, then I would feel cautious watching any rally reach the 6.60- 7.00 area.
Personally, my bias remains neutral but looking for the next selling attack to try bleeding price back down to the 5.00 and even into the 4.80/4.70 target zone, maybe October. A slow stretch looking like sideways, that bleeds and tumbles into late October. For bargains to buy again around 4.90. What rally we get now, from 5.50 to 6.20 maybe 6.50.... could get hammered down, in the typical AVXL pattern... while we wait and wait, and wait for the rest of the year. Long time frame to watch. 🎱🫡🫣🥱
I don’t know what “normal” volume means on your planet but the average daily volume in AVXL is 986,660. Today’s volume was 418,847. That’s 56.53% lower than the average daily volume. Safe to say today’s volume was not higher than normal. In fact, the volume was pretty light. With the stock bobbing up and down aimlessly on low volume, there is clearly no investor expectation of HUGE NEWS on Thursday.
And by the way, predicting that the stock will close higher on an up day with 45 minutes to the close isn’t exactly remarkable.
AVXL stock was near the high of the day and the closing volume was indeed higher than normal.
Good luck and GOD bless,
Contrary to George's statement. Today looks to be about the LOWEST VOLUME I have ever seen. 280K shares with 20minutes till the bell.
John k9uwa
I think you mean “pretend” to own other stocks that he can be assigned to bash.
You do realize you are allowed to sell and buy other stocks instead?
Another lie. You have no shame.
You must be as excited as they are. Up 8 pennies.
It's green. Sheesh.
Expect AVXL to close at or near the high of the day on higher than normal volume.
Good luck and GOD bless,
Here comes the end of day selloff. Each and every day. Will this stock ALWAYS be a POS?
Check YOUR cookies.
Much more likely "link" issue.
Same as Sarasota so no different Season to us.
Do notice the breeze of the Atlantic is much more of influence
than the bath water Gulf differential.
Grease Trap on the outdoor grill.
I'll make a plaque.
Agree about Sarasota. We are midstate 170' above Sea Level. I have a "Rule" re: Grass and Snow. I didn't put it there I am not moving it!! Landlords we are. 14 homes. 2 to live in and a dozen rentals zero mort's. Haven't been in snow for over 20 years. Don't enjoy watching it on TeeVee. As to George I don't think posters pay much attention. Any new posters would read many more postings than just George's. Enough to get the idea that George is wrong most of the time.
John k9uwa
SAVA recovered all yesterday's loss but this POS has no volume. Hope this don't become next BIVI.
AVXL up a whopping 10 cents on anticipation of HUGE NEWS on Thursday, September 26, 2024.
Anyone notice that for a fair few months if you put "Anavex" into google and filter by last 24 hours it often comes up with the EMA page and sometimes FDA from the last few hours?
There is nothing actually on there about anavex if you click (at-least that is publicly viewable) but it would seem perhaps it's on their system somewhere and in some form getting refreshed or something which might cause this? I don't seem to notice it for other drug stocks if I filter by last 24 hours.
What? You don't consider a cat 3 seasonal?
Ahh how wonderful it is to be free to make our own mistakes.
Just don't go around flaunting about them.
I suspect nobody cares but is nice to know I hold small spot in that house....
Sounds like a personal problem.
Fool me once shame on you.
Fool me twice.....
Do you really imagine any serious money inflow to AVXL stock
based upon a first impression of George?
Even if the young wolfen whippersnapper here questioned the new home purchase in NC
my wife (Westport, CT native) is happy with decorating and looking forward
to more Seasonal influence than Sarasota.
I'll sacrifice the extra 2-3% for 2 years max on 600K before decent rate refi
for the satisfaction of moving her when she wishes.
Probably got that on the accepted offer price anyway.
I'll never shovel snow though so bring a backhoe and bury me here.
"All the above is a lot easier to justify" I once spent 4 hours trying to count the buys and sells. Wasn't half way through and said have other things more important to do. Sunday we snuck past you Leo. Arrived just in time to batten down the hatches.
John k9uwa
I guess you are naive. And don't understand the human condition and desperation. Not over the top at all even I when new tried to couple my research with whom I thought to be credible and was duped by the George infomercial. He I didn't lose much from his false credibility...but he is a criminal.
Another GREAT week that's not starting out very great
I'm so excited! I can hardly wait!
Misleading is dragging this till CTAD then he will go into coma till mid next year.
Medical quackery targeting frightened people. Sound familiar?
Anti-Aging Enthusiasts Are Taking a Pill to Extend Their Lives.
https://www.nytimes.com/2024/09/24/well/live/rapamycin-aging-longevity-benefits-risks.html?utm_source=newsshowcase&utm_medium=gnews&utm_campaign=CDAQtpmN24KijKcmGLXzzemjjdn9sgEqDwgAKgcICjCO64oDMJavPA&utm_content=related&gaa_at=la&gaa_n=AWsEHT5I2FwPYRP-B_qeITHslMwNwD8svsCsepy5aLpnocF_WCu8ek0yOx9eRs9AhOETtIZwKTNp8Y1SpSXr&gaa_ts=66f2bec8&gaa_sig=qd8NOg6doF6w6GImNBvysYeFSXssb6nUIBeVcd7gnecykbddxV61Ih5GV8uky35oGiIDMdMcArpzyucuemwtyQ%3D%3D
Comparison of possible binding modes of Anavex2-73 to that of rapamycin
https://www.biotechtoinvest.com/research/2022/5/15/the-answer-was-here-all-the-time-why-anavex2-73-can-stop-alzheimers-disease
Good luck and GOD bless,
George has promised HUGE NEWS on Thursday.
Just have to be patient.🤷♂️
Sweet f’all as far as I can tell. With luck we’ll only lose a few percent more today.
For all the agenda participating on this forum, I often feel lucky mine is to attempt to advantage a stock price which for approaching a decade has fluctuated at times violently.
That does not deny a hope pursuit of the Science is successful. It does accept a critical approach to the reality of that pursuit.
All the above is a lot easier to justify than
WGT
or
Throw the bum out.
Good Luck with those agenda.
Lol.. Hey, Bourbon. Good to hear from you. I think it's because of the corrupt market. Unfair MC valuation of Anavex.
One of the most abused English phrases.
At the very least, understanding why that is so should lend focus to the arguments you wish to articulate.
Here is a way to link up. Falconner I think you will soak this up if you havent already seen it.
Google below:
Dr. Jack Kruse and Andrew Huberman Youtube
Watch the pre-market trading of AVXL this week!!!
Good luck and GOD bless,
Forget it, it'll disappear just like the PDD data into the dustbin of history never to be heard from again. And then they will focus on 371 for the next decade.
Zzzzzzzzzzzz...Zzzzzzzzzzzz
Nothing to see here
EMA filing, where are you?
Oh perfect, Just what we need. Another jarbled presentation from Dr Missling to drive the stock price down further on that day. BOD has not figured this out apparently. Let Dr Jin present please.
This dude is so eager to control expectations downwardly for every upcoming catalyst, one would have to be obtuse to not recognize his angle. Clearly, either he or his masters suddenly have ample reason to support that angle at all costs (ie they’re in serious danger of losing control of the SP), the product of which is nonsensical FUD to anyone with a brain. The desperation is palpable, off the charts compared to his normal fare. How could you not enjoy watching him squirm?
I believe only new not previously disclosed data is presented at these conferences.
At the very least I’m hoping for the OLE data, which if good should get the wheels turning.
This is from ST, looks like Fragile X got it's drug. Misleading always late, kick the can...
https://www.npr.org/sections/shots-health-news/2024/09/22/nx-s1-5076913/fragile-x-experimental-drug-helping-autism-adhd-intellectual-disability
Yup..that's why you responded to me in 4 minutes, tons of people here with $6-7 million to distribute are on anonymous message boards constantly...I'm killing time before Bills game
I guess we will see how things turn out.
I disagree with your outlook. For example, Anavex could announce a partnership at any time.
It doesn't look good for sparkly bicycles this Christmas.
Followers
|
1086
|
Posters
|
|
Posts (Today)
|
37
|
Posts (Total)
|
470103
|
Created
|
12/18/07
|
Type
|
Free
|
Moderators RedShoulder Steady_T Bourbon_on_my_cornflakes kund mike_dotcom nidan7500 |
Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer. The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.
Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease. ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others. The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial. ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.
The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.
Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL
.Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |